TotalMarketCap

Dianthus Therapeutics

DNTHNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.691 B

$83.30 -2.92%

Close of 6 Nov 2026

As of 6 Nov 2026, Dianthus Therapeutics (DNTH) has a market capitalization of $4.69B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.04M

#3395 by revenue

Earnings

-$162.3M

Loss-making

Shares outstanding

56,312,712

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #54Cogent BiosciencesCOGT$5.14B
  2. #55Travere TherapeuticsTVTX$4.70B
  3. #56Dianthus TherapeuticsDNTH$4.69B
  4. #57ErascaERAS$4.64B
  5. #58Legend BiotechLEGN$4.39B

What if Dianthus Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$501,429.83

Per share 6,020× higher

Bitcoin $1.53T

$27,131.50

Per share 326× higher

Apple $5.02T

$89,070.17

Per share 1,069× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Dianthus Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.